Is a single fund the answer to the UK's research and development needs?
This article was originally published in Clinica
Executive Summary
Would the UK's medtech R&D base benefit from merging the NHS R&D programme with the Medical Research Council (MRC)? Such a move is crucial to ensuring that the UK medical science is internationally competitive, in the way that the MRC has proven to be, argues Richard Horton, editor of The Lancet, in view of a forthcoming review of policy in this area.